サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1514248

女性の健康治療の世界市場

Women's Health Therapeutics

出版日
ページ情報
英文 92 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
女性の健康治療の世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 92 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

女性の健康治療薬の世界市場は2030年までに454億米ドルに達する

2023年に196億米ドルと推定される女性女性の健康治療の世界市場は、2023～2030年の分析期間においてCAGR 12.7%で成長し、2030年には454億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである閉経後骨粗鬆症アプリケーションは、CAGR 14.9%を記録し、分析期間終了までに181億米ドルに達すると予測されます。ホルモン性不妊症応用分野の成長率は、分析期間中CAGR 10.3％と推定されます。

米国市場は51億米ドルと推定される一方、中国はCAGR 17.0％で成長すると予測される

米国の女性健康治療薬市場は、2023年に51億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに113億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは17.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.4%と10.7%と予測されています。欧州では、ドイツがCAGR約9.8%で成長すると予測されています。

世界の女性の健康治療市場- 主な促進要因と動向のまとめ

女性の健康治療は、女性に影響を与える健康問題に対処するために特別に設計された幅広い治療とソリューションを包含します。このカテゴリーには、乳がん、子宮頸がん、骨粗しょう症、更年期障害、生殖機能障害など、女性特有の、あるいは女性に多く見られる疾患を対象とした薬物療法、治療法、予防治療が含まれます。これらの治療薬は、様々なライフステージにある女性のQOL（生活の質）と健康状態を改善し、身体と生殖の両面の健康をサポートすることを目的としています。思春期から閉経後まで、様々なライフステージの女性に対応する健康サービスへの需要が高まる中、女性の健康治療の市場は拡大しています。

女性の健康治療の市場を牽引しているのは、いくつかの重要な要因であり、特に女性の健康問題に対する認識と支持の高まりです。公衆衛生キャンペーンや女性擁護団体は、乳がんや卵巣がんなどの病気に対する認識を高め、早期診断や早期治療につなげる上で極めて重要な役割を担っています。高齢の女性は、心血管疾患、骨粗鬆症、更年期障害などの慢性的な健康問題を経験する可能性が高くなるためです。さらに、医薬品とバイオテクノロジーの進歩により、女性特有の疾患に対するより効果的な治療法が開発され、患者の予後を改善し、寿命を延ばすことにつながっています。こうした進歩には、ホルモン補充療法、標的がん治療、不妊治療の改善などが含まれ、いずれも近年大きな技術革新と採用が見られます。

女性の健康治療市場の最近の動向は、個別化医療と標的治療へのシフトを示しています。特に乳がんや卵巣がんなど、バイオマーカーや遺伝子検査によって治療効果を予測できる分野では、個々の患者の遺伝子プロファイルや分子プロファイルに合わせた治療法の開発に注目が集まっています。さらに、更年期障害の症状を管理するための非ホルモン療法の研究開発への投資も増加しています。これは、重大な副作用を伴う可能性のある従来のホルモン補充療法に代わる治療法に対する需要に後押しされたものです。もう一つの注目すべき動向は、モバイルヘルスアプリやウェアラブルデバイスを含むデジタルヘルス技術の統合であり、重要な健康指標を追跡し、パーソナライズされた健康洞察を提供することで女性の健康管理をサポートするように設計されています。これらの技術は、女性が自分の健康を管理できるようにする上で重要な役割を果たしており、様々な健康状態の予防、早期発見、管理のためのツールを提供しています。

調査対象企業の例（注目の36社）

  • AstraZeneca
  • Bayer AG
  • Bristol-Myers Squibb Company
  • CooperSurgical, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP23094

Global Women's Health Therapeutics Market to Reach US$45.4 Billion by 2030

The global market for Women Women's Health Therapeutics estimated at US$19.6 Billion in the year 2023, is expected to reach US$45.4 Billion by 2030, growing at a CAGR of 12.7% over the analysis period 2023-2030. Postmenopausal Osteoporosis Application, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$18.1 Billion by the end of the analysis period. Growth in the Hormonal Infertility Application segment is estimated at 10.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.1 Billion While China is Forecast to Grow at 17.0% CAGR

The Women's Health Therapeutics market in the U.S. is estimated at US$5.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$11.3 Billion by the year 2030 trailing a CAGR of 17.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.4% and 10.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.

Global Women's Health Therapeutics Market - Key Drivers and Trends Summarized

Women's health therapeutics encompass a broad range of medical treatments and solutions specifically designed to address health issues that affect women. This category includes medications, therapies, and preventive treatments targeting conditions unique to or more prevalent in women, such as breast cancer, cervical cancer, osteoporosis, menopause, and reproductive health disorders. These therapeutics aim to improve the quality of life and health outcomes for women across various life stages, supporting both physical and reproductive health. With an increasing demand for health services that cater to women through various stages of life—from puberty to post-menopause—the landscape of women's health therapeutics is expanding.

The market for women's health therapeutics is driven by several key factors, notably the increasing awareness and advocacy around women's health issues. Public health campaigns and women's advocacy groups have been pivotal in increasing awareness about diseases such as breast and ovarian cancer, leading to earlier diagnosis and treatment. The aging female population globally is another significant driver, as older women are more likely to experience chronic health issues such as cardiovascular diseases, osteoporosis, and menopausal health concerns. Furthermore, advancements in pharmaceuticals and biotechnology have led to the development of more effective treatments for conditions specific to women, enhancing patient outcomes and extending life expectancies. These advancements include hormone replacement therapies, targeted cancer therapies, and improved fertility treatments, which have all seen significant innovation and adoption in recent years.

Recent trends in the women's health therapeutics market indicate a shift towards personalized medicine and targeted therapies. There is a growing focus on developing treatments tailored to the genetic and molecular profiles of individual patients, particularly in areas such as breast and ovarian cancer, where biomarkers and genetic tests can predict treatment responses. Additionally, there is an increasing investment in research and development of non-hormonal therapies for managing menopause symptoms, driven by the demand for alternatives to traditional hormone replacement therapies, which can have significant side effects. Another notable trend is the integration of digital health technologies, including mobile health apps and wearable devices, designed to support women's health management by tracking vital health metrics and providing personalized health insights. These technologies are playing a crucial role in empowering women to take charge of their health, offering tools for prevention, early detection, and management of various health conditions

Select Competitors (Total 36 Featured) -

  • AstraZeneca
  • Bayer AG
  • Bristol-Myers Squibb Company
  • CooperSurgical, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Women's Health Therapeutics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases in Women
    • Growing Awareness and Focus on Women's Health Issues
    • Advancements in Hormonal Therapies
    • Expansion of Personalized Medicine in Women's Health
    • Rising Demand for Non-Invasive Therapeutic Solutions
    • Adoption of Digital Health Technologies and Telemedicine
    • Increasing Investment in Women's Health Startups
    • Impact of Aging Population on Therapeutics Demand
    • Development of Novel Drug Delivery Systems
    • Expansion of Preventive Healthcare Services
    • Influence of Lifestyle Changes and Urbanization
    • Rising Demand for Fertility and Reproductive Health Solutions
    • Growing Importance of Mental Health and Wellness for Women
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Women's Health Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Women's Health Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Women's Health Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Postmenopausal Osteoporosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Postmenopausal Osteoporosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Postmenopausal Osteoporosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hormonal Infertility by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hormonal Infertility by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Hormonal Infertility by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Polycystic Ovary Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Polycystic Ovary Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Polycystic Ovary Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Endometriosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Endometriosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Endometriosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Contraceptives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Menopause by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Menopause by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Women's Health Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Women's Health Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Women's Health Therapeutics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Europe 16-Year Perspective for Women's Health Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 44: France Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: France Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: France 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 47: Germany Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Germany Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Germany 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Italy 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 53: UK Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: UK Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: UK 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 56: Spain Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Spain Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Spain 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 59: Russia Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Russia Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Russia 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of Europe Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Rest of Europe 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 65: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Asia-Pacific Historic Review for Women's Health Therapeutics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Asia-Pacific 16-Year Perspective for Women's Health Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 68: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Asia-Pacific Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Asia-Pacific 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 71: Australia Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Australia Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Australia 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 74: India Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: India Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: India 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 77: South Korea Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: South Korea Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: South Korea 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 80: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Asia-Pacific Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Asia-Pacific 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 83: Latin America Recent Past, Current & Future Analysis for Women's Health Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 84: Latin America Historic Review for Women's Health Therapeutics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Latin America 16-Year Perspective for Women's Health Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 86: Latin America Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Latin America Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Latin America 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 89: Argentina Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Argentina Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Argentina 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 92: Brazil Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Brazil Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Brazil 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 95: Mexico Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Mexico Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Mexico 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 98: Rest of Latin America Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Latin America Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Latin America 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 101: Middle East Recent Past, Current & Future Analysis for Women's Health Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 102: Middle East Historic Review for Women's Health Therapeutics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Middle East 16-Year Perspective for Women's Health Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 104: Middle East Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Middle East Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Middle East 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 107: Iran Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Iran Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Iran 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 110: Israel Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Israel Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Israel 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 113: Saudi Arabia Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Saudi Arabia Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Saudi Arabia 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 116: UAE Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UAE Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UAE 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 119: Rest of Middle East Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Middle East Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Middle East 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Women's Health Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 122: Africa Recent Past, Current & Future Analysis for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Africa Historic Review for Women's Health Therapeutics by Application - Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Africa 16-Year Perspective for Women's Health Therapeutics by Application - Percentage Breakdown of Value Sales for Postmenopausal Osteoporosis, Hormonal Infertility, Polycystic Ovary Syndrome, Endometriosis, Contraceptives, Menopause and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION